Open AccessPeer review of the pesticide risk assessment of the active substances Pepino Mosaic Virus , EU strain, mild isolate Abp1 and Pepino Mosaic Virus , CH 2 strain, mild isolate Abp2
Author(s) -
Anastassiadou Maria,
Arena Maria,
Auteri Domenica,
Brancato Alba,
Bura Laszlo,
Carrasco Cabrera Luis,
Chaideftou Eugenia,
Chiusolo Arianna,
Crivellente Federica,
De Lentdecker Chloe,
Egsmose Mark,
Fait Gabriella,
Greco Luna,
Ippolito Alessio,
Istace Frederique,
Jarrah Samira,
Kardassi Dimitra,
Leuschner Renata,
Lostia Alfonso,
Lythgo Christopher,
Magrans Oriol,
Mangas Iris,
Miron Ileana,
Molnar Tunde,
Padovani Laura,
Parra Morte Juan Manuel,
Pedersen Ragnor,
Reich Hermine,
Santos Miguel,
Sharp Rachel,
Szentes Csaba,
Terron Andrea,
Tiramani Manuela,
Vagenende Benedicte,
VillamarBouza Laura
Publication year - 2021
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2021.6388
Subject(s) - context (archaeology) , strain (injury) , virus , european union , biology , virology , cucumber mosaic virus , microbiology and biotechnology , plant virus , business , paleontology , anatomy , economic policy
The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, Spain, for the pesticide active substances Pepino Mosaic Virus, EU strain, mild isolate Abp1 and Pepino Mosaic Virus, CH 2 strain, mild isolate Abp2 and the considerations as regards the inclusion of the substances in Annex IV of Regulation ( EC ) No 396/2005 are reported. The context of the peer review was that required by Regulation ( EC ) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the evaluation of the representative use of Pepino Mosaic Virus, EU strain, mild isolate Abp1 and Pepino Mosaic Virus, CH 2 strain, mild isolate Abp2 as an elicitor on tomato (permanent greenhouse production systems). The reliable endpoints, appropriate for use in regulatory risk assessment, are presented. Missing information identified as being required by the regulatory framework is listed.